Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials (Q31138857)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials |
scientific article |
Statements
1 reference
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials (English)
1 reference
1 reference
Caryn Lerman
1 reference
Raymond Niaura
1 reference
Elizabeth E Lloyd-Richardson
1 reference
Paul E Wileyto
1 reference
David R Strong
1 reference
Richard A Brown
1 reference
Eden A Evins
1 reference
Peter G Shields
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference